Total liabilities · 2011–2025
Vanda Pharmaceuticals total liabilities
$162M+37.5% · FY2025
Vanda Pharmaceuticals (VNDA) reported $162M in total liabilities for fiscal 2025, +37.5% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $162M | +37.5% | Open → |
| FY20242024-12-31 | $118M | +13.6% | Open → |
| FY20232023-12-31 | $104M | −3.3% | Open → |
| FY20222022-12-31 | $107M | +20.5% | Open → |
| FY20212021-12-31 | $88.9M | +10.8% | Open → |
| FY20202020-12-31 | $80.2M | +10.1% | Open → |
| FY20192019-12-31 | $72.8M | +28.4% | Open → |
| FY20182018-12-31 | $56.7M | −23.4% | Open → |
| FY20172017-12-31 | $74.0M | −6.3% | Open → |
| FY20162016-12-31 | $79.0M | −1.2% | Open → |
| FY20152015-12-31 | $80.0M | +635.0% | Open → |
| FY20142014-12-31 | $10.9M | −89.0% | Open → |
| FY20132013-12-31 | $99.2M | −21.0% | Open → |
| FY20122012-12-31 | $126M | −15.8% | Open → |
| FY20112011-12-31 | $149M | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +0.6%
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Vanda Pharmaceuticals total liabilities |url=https://companiesranked.com/en/company/vanda-pharmaceuticals/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Vanda Pharmaceuticals total liabilities. CompaniesRanked. https://companiesranked.com/en/company/vanda-pharmaceuticals/total-liabilitiesBibTeX
@misc{companiesranked-en-company-vanda-pharmaceuticals-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{Vanda Pharmaceuticals total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/vanda-pharmaceuticals/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001628280-26-053855 · August 6, 2026
{{cite web |title=Vanda Pharmaceuticals total liabilities — 10-Q (0001628280-26-053855) |url=https://www.sec.gov/Archives/edgar/data/1347178/000162828026053855/vnda-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.